Jacque Sokolov
Follow
Get notifications in MyBN when activity occurs.
Jacque Sokolov
Non-Executive Director / Artrya
Dr Jacque Sokolov is a recognised leader in the US healthcare care sector, having advised companies across the US and government entities including the White House under four presidents, Senate and House committees.
Dr Sokolov is the chair and chief executive of SSB Solutions Inc, a US diversified healthcare management, development, and financial services company which has worked with more than 100 healthcare organisations across multiple US healthcare sectors to develop physician-driven, value-focused solutions in rapidly evolving markets.
Dr Sokolov holds a Bachelor of Arts in Medicine, a Doctor of Medicine, and completed his internal medicine residency at the Mayo Graduate School of Medicine followed by his fellowship in cardiovascular diseases/nuclear cardiology from the University of Texas-Southwestern Medical School.
Dr Sokolov is the chair and chief executive of SSB Solutions Inc, a US diversified healthcare management, development, and financial services company which has worked with more than 100 healthcare organisations across multiple US healthcare sectors to develop physician-driven, value-focused solutions in rapidly evolving markets.
Dr Sokolov holds a Bachelor of Arts in Medicine, a Doctor of Medicine, and completed his internal medicine residency at the Mayo Graduate School of Medicine followed by his fellowship in cardiovascular diseases/nuclear cardiology from the University of Texas-Southwestern Medical School.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 101st | Artrya | 141% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Artrya | $3.7m |
200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEWS: Tagged in US expert joins Perth medtech company | 01 Aug 2022 |
| NEW ROLE: Non-Executive Director, Artrya | 01 Aug 2022 |
